Correction to: Scientific Reports 10.1038/s41598-017-18892-9, published online 15 January 2018
This Article contains errors in the Methods section, under subsection ‘Cloning of antibodies’.
“VL and VH genes of Trastuzumab (PDB: 1N8Z) and Pertuzumab (PDB: 1S78) were synthesized (Blue Heron Biotech LLC). The VL were joined to Cκ (Accession no: AKL91149.1) and Cλ (Cλ1: Accession X51755; Cλ2: Accession J00253; Cλ3: Accession X06876; Cλ6: Accession J03011; Cλ7: Accession X51755) forming the light chain, while the VH were joined to CH isotype/subtypes (CHμ: Accession AAS01769.1; CHα1: Accession P01876.2; CHα2: Accession AAT74071.1; CHγ1: Accession AAA02914.1; CHγ2: Accession AAG00910.2; CHγ3: Accession P01860.2; CHγ4: Accession P01861.1; CHδ: Accession AAA52770.1; and CHε: Accession P01854.1) to form the heavy chain construct in cloning cassettes previously described36. The cassettes were cloned into pTT5 plasmid (YouBio) and transformed into competent DH5α bacteria37 as previously described.”
should read:
“VL and VH genes of Trastuzumab (PDB: 1N8Z) and Pertuzumab (PDB: 1S78) were synthesized (Blue Heron Biotech LLC). The VL were joined to Cκ (Accession no: AKL91149.1) and Cλ (Cλ1: Accession P0CG04.1; Cλ2: Accession P0DOY2.1; Cλ3: Accession P0DOY3.1; Cλ6: Accession P0CF74.1; Cλ7: Accession AAB59435.1) forming the light chain, while the VH were joined to CH isotype/subtypes (CHμ: Accession AAS01769.1; CHα1: Accession P01876.2; CHα2: Accession AAT74071.1; CHγ1: Accession AAA02914.1; CHγ2: Accession AAG00910.2; CHγ3: Accession P01860.2; CHγ4: Accession P01861.1; CHδ: Accession AAA52770.1; and CHε: Accession P01854.1) to form the heavy chain construct in cloning cassettes previously described 36. The cassettes were cloned into pTT5 plasmid (YouBio) and transformed into competent DH5α bacteria37 as previously described.”